3
Announcements
Trials
Browse
Landscape
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Observational
1
Sponsor
Cancer Type
Gynecologic
1
Gastrointestinal
1
Classical hematology
1
Breast
1
Conditions
Sleep Initiation and Maintenance Disorders
19
Breast Neoplasms
14
Neoplasms
12
Anxiety Disorders
7
Prostatic Neoplasms
6
Depression
5
Motor Activity
3
Lymphoma
3
Weight Loss
2
Pain
2
Overweight
2
Ovarian Neoplasms
2
Obesity
2
Multiple Myeloma
2
Lung Neoplasms
2
Glioblastoma
2
Fatigue
2
Colorectal Neoplasms
2
Uterine Neoplasms
1
Uterine Cervical Neoplasms
1
Squamous Cell Carcinoma of Head and Neck
1
Smoking Cessation
1
Smoking
1
Small Cell Lung Carcinoma
1
Sleep Wake Disorders
1
Sexual Dysfunctions, Psychological
1
Sexual Dysfunction, Physiological
1
Sedentary Behavior
1
Polycystic Ovary Syndrome
1
Pancreatic Neoplasms
1
Interventions
olaparib
6
talazoparib
1
liposomal doxorubicin
1
iniparib
1
Surveys and Questionnaires
1
Secretin
1
Genetic Counseling
1
Demography
1
Data Collection
1
Counseling
1
Cognitive Behavioral Therapy
1
Carboplatin
1
Biopsy, Fine-Needle
1
ABT-767
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Completed
×
Fanconi Anemia, Complementation Group D1
×
Cognitive Behavioral Therapy
×
Clear all
NCT03889171
2019-03-28
PSICOM
University Hospital, Montpellier
Completed
200 enrolled